This inventor holds 1 USPTO granted patent. Top assignee: University of Illinois. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Ylena V Grinkova: Innovator in Membrane Scaffold Proteins
Introduction
Ylena V Grinkova is a prominent inventor based in Urbana, IL (US). She has made significant contributions to the field of biochemistry, particularly in the development of membrane scaffold proteins. Her innovative work has implications for pharmaceutical and biological research.
Latest Patents
Ylena holds a patent for "Membrane Scaffold Proteins." This invention involves the assembly of membrane scaffold proteins (MSP) with hydrophobic or partially hydrophobic proteins to create soluble nanoscale particles. These particles maintain their native structure and function, offering advantages over traditional liposomes and detergent micelles in terms of stability and biological activity. The MSPs form nanoscopic phospholipid bilayer disks in the presence of phospholipids, which stabilize the particle at the perimeter of the bilayer domain. This structure allows for the manipulation of incorporated proteins, facilitating various applications in drug discovery and bioseparations.
Career Highlights
Ylena is affiliated with the University of Illinois, where she continues her research and development in innovative biotechnological solutions. Her work has garnered attention for its potential to enhance the understanding of protein structures and functions.
Collaborations
Ylena collaborates with notable colleagues, including Natanya R Civjan and Ilia G Denisov. These partnerships contribute to the advancement of her research and the exploration of new applications for her inventions.
Conclusion
Ylena V Grinkova's contributions to the field of membrane scaffold proteins exemplify the impact of innovative research in biotechnology. Her work not only advances scientific understanding but also paves the way for future developments in drug discovery and biological research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
